4/A
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-046268
Options or other derivatives
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-046268
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…